- Home
- GBIO vs STEC Comparison
GBIO vs STEC Comparison
Compare GBIO & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- STEC
- Stock Information
- Founded
- GBIO 2016
- STEC 2006
- Country
- GBIO United States
- STEC Hong Kong
- Employees
- GBIO N/A
- STEC N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- STEC
- Sector
- GBIO Health Care
- STEC
- Exchange
- GBIO Nasdaq
- STEC NYSE
- Market Cap
- GBIO 29.2M
- STEC 29.7M
- IPO Year
- GBIO 2020
- STEC 2021
- Fundamental
- Price
- GBIO $0.39
- STEC $0.80
- Analyst Decision
- GBIO Strong Buy
- STEC
- Analyst Count
- GBIO 4
- STEC 0
- Target Price
- GBIO $7.33
- STEC N/A
- AVG Volume (30 Days)
- GBIO 1.1M
- STEC 14.1K
- Earning Date
- GBIO 08-06-2025
- STEC 07-22-2025
- Dividend Yield
- GBIO N/A
- STEC N/A
- EPS Growth
- GBIO N/A
- STEC N/A
- EPS
- GBIO N/A
- STEC N/A
- Revenue
- GBIO $24,556,000.00
- STEC $10,672,000.00
- Revenue This Year
- GBIO N/A
- STEC $9,392.20
- Revenue Next Year
- GBIO N/A
- STEC N/A
- P/E Ratio
- GBIO N/A
- STEC N/A
- Revenue Growth
- GBIO 146.47
- STEC N/A
- 52 Week Low
- GBIO $0.30
- STEC $0.20
- 52 Week High
- GBIO $3.65
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- GBIO 52.02
- STEC 38.10
- Support Level
- GBIO $0.32
- STEC $0.81
- Resistance Level
- GBIO $0.36
- STEC $0.88
- Average True Range (ATR)
- GBIO 0.03
- STEC 0.07
- MACD
- GBIO 0.00
- STEC -0.00
- Stochastic Oscillator
- GBIO 81.00
- STEC 15.97
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.